April 7, 2014 | Five former portfolio companies from the RAD BioMed accelerator have raised a total of $7 million in follow-on investments from the RAD Group and additional private investors. “Globes” reports that The companies are VGS Ltd., which has developed a method for reducing rejection of vein grafts; Vectorious Medical Technologies Ltd., which has developed an implant for early diagnosis of heart failure; Laminate Medical Technologies Ltd., which is developing an implant for improving renal vascular procedures; Perflow Medical Ltd., which is developing endovascular device for removing blood clots during brain surgery to prevent ischemic stroke; and Moebius Medical Ltd., which has developed liposomal lubricants for treating osteoarthritis.
Facebook comments